User profiles for Murray Krahn

Murray Krahn

THETA, Toronto General Hospital Research Institute, University of Toronto
Verified email at theta.utoronto.ca
Cited by 24234

Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine

…, PJ Neumann, A Basu, DW Brock, D Feeny, M Krahn… - Jama, 2016 - jamanetwork.com
Importance Since publication of the report by the Panel on Cost-Effectiveness in Health and
Medicine in 1996, researchers have advanced the methods of cost-effectiveness analysis, …

[PDF][PDF] Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: a meta‐analysis and meta‐regression

HH Thein, Q Yi, GJ Dore, MD Krahn - Hepatology, 2008 - Wiley Online Library
Published estimates of liver fibrosis progression in individuals with chronic hepatitis C virus (HCV)
infection are heterogeneous. We aimed to estimate stage‐specific fibrosis …

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

HH Thein, Q Yi, GJ Dore, MD Krahn - Aids, 2008 - journals.lww.com
Objectives: To estimate stage-specific transition probabilities in individuals coinfected with
HIV and hepatitis C virus (HCV), to examine the effect of covariates on these rates, and to …

Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force–2

…, M Chambers, P McEwan, M Krahn - Medical Decision …, 2012 - journals.sagepub.com
The appropriate development of a model begins with understanding the problem that is
being represented. The aim of this article is to provide a series of consensus-based best …

Screening for prostate cancer: a decision analytic view

MD Krahn, JE Mahoney, MH Eckman, J Trachtenberg… - Jama, 1994 - jamanetwork.com
Objective. —To determine the clinical and economic effects of screening for prostate cancer
with prostate-specific antigen (PSA), transrectal ultrasound (TRUS), and digital rectal …

Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005

…, SG Goodman, R Petrella, M O'Flaherty, M Krahn… - Jama, 2010 - jamanetwork.com
Context Coronary heart disease (CHD) mortality has declined substantially in Canada since
1994. Objective To determine what proportion of this decline was associated with temporal …

The effect of English language proficiency on length of stay and in-hospital mortality

…, WL Gold, H Abrams, M Bacchus, M Krahn - Journal of general …, 2004 - Springer
BACKGROUND: In ambulatory care settings, patients with limited English proficiency receive
lower quality of care. Limited information is available describing outcomes for inpatients. …

The next step in guideline development: incorporating patient preferences

M Krahn, G Naglie - Jama, 2008 - jamanetwork.com
CLINICAL PRACTICE GUIDELINES (CPGS) ARE SYSTEM-atically developed statements to
assist both pa-tient and practitioner decisions. A fixture of modern medical care, guidelines …

Health-state utilities and quality of life in hepatitis C patients

…, L Lilly, M Sherman, G Naglie, M Krahn - Official journal of the …, 2003 - journals.lww.com
OBJECTIVE: Health-state utilities are global measurements of quality of life on a scale from
0 (death) to 1 (full health). Utilities are used to evaluate health outcomes and are the …

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses

…, WJ Ungar, TR Einarson, EJ Heathcote, M Krahn - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: The relative efficacies of licensed antiviral therapies for treatment-naive
chronic hepatitis B (CHB) infection in randomized controlled trials have not been …